NCT06370039View on ClinicalTrials.gov

Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

109

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

July 3, 2024

Study Completion Date

July 3, 2024

Conditions

Dry Eye Disease

Interventions

DRUG

INV-102

INV-102 Ophthalmic Solution

DRUG

Vehicle

Vehicle Ophthalmic Solution

Trial Locations (1)

14543

iuvo BioScience, Rush

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Invirsa, Inc.

INDUSTRY